Keyphrases
Tumor
100%
Metabolic
96%
Genome-scale Metabolic Model
85%
Metabolic Modeling
74%
T Cells
71%
Single-cell RNA Sequencing (scRNA-seq)
67%
PD-1 Blockade
65%
CD8+ T Cells
63%
Immune Cells
54%
Melanoma
54%
Drug Target
53%
Programmed Death-ligand 1 (PD-L1)
49%
Cell State
47%
Metabolomics Data
46%
Transcriptome
45%
PD-1 Resistance
42%
Checkpoint Immunotherapy
42%
Glioma
42%
Immune Checkpoint Therapy
40%
Cancer Cells
40%
Metabolic Network
32%
Gene Loss
31%
Metabolism
31%
Tumor Microenvironment
31%
Response Predictors
31%
Metabolic Pathway
31%
Isocitrate Dehydrogenase 1 (IDH1)
29%
Transcriptomic Data
29%
TCF7
28%
Warburg Effect
28%
Tertiary Lymphoid Structures
28%
Genome-scale
28%
Metabolic Alterations
27%
Oligodendroglioma
26%
Developmental Hierarchies
26%
Proteomics Data
25%
Transcriptomics
25%
Tumor mutational Burden
25%
B Cells
25%
Cancer Immunotherapy
25%
RNA Sequencing (RNA-seq)
25%
Clonal Expansion
24%
Melanoma Cells
24%
Malignant Cells
24%
Cancer Metabolism
23%
Transcription Factor
22%
Somatic mutation
22%
Immune Checkpoint Blockade
22%
Genetic Lineages
21%
Exchange Flux
21%
Biochemistry, Genetics and Molecular Biology
RNA Sequence
97%
T Cell
95%
Cancer Cell
66%
Immune Checkpoints
63%
Genetics
62%
Metabolic Network
46%
Transcriptome
45%
Immunocompetent Cell
44%
Metabolomics
42%
Somatic Mutation
42%
Metabolic Pathway
42%
Cell Proliferation
37%
Enzyme
31%
Metabolite
29%
Hexose Monophosphate Shunt
28%
Transcriptomics
27%
RNA
26%
Cancer Immunotherapy
26%
RNA Sequencing
25%
Immunity
24%
Gene Loss
23%
Volume
21%
Cancer Stem Cell
21%
Warburg Effect
21%
Essential Gene
21%
Genetic Redundancy
21%
Beta-2 Microglobulin
21%
Protein Sequencing
21%
TANK-binding Kinase 1
21%
Lineage (Genetic)
21%
Esophagus
21%
Oncogene
21%
Gene Expression Profiling
21%
Tumor Gene
21%
Antigen Presentation
21%
Endosymbiont
21%
Alternative Splicing
21%
Gluconeogenesis
21%
Mosaicism
21%
Quantitative Proteomics
21%
Cell Division
21%
Mesenchymal-Epithelial Transition
21%
Microorganism
21%
Isocitrate Dehydrogenase
21%
Cell Growth
21%
P53
21%
Pyrimidine Biosynthesis
21%
Evolution
21%
Aspartic Acid
21%
Radiosensitivity
21%